Revealing Engagement Patterns Among Hepatic Encephalopathy Patients
ConditionHepatic Encephalopathy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.
In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.
Eligibility criteria
Qualifiers
Signed Written Informed Consent
Aged ≥ 18 years old
No prior treatment for hepatic encephalopathy
Disqualifiers
Participant is actively receiving study therapy in another
Inability to provide written informed consent
Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov